Holliston, MA – January 2, 2020 – Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), a bioengineering company developing next-generation esophageal implants, received the anticipated formal response from the U.S. Food and Drug Administration (FDA) related to the Compa...

Boston, MA -- January 5, 2020 -- Techlobe raised $24 million in a Series B financing, The round was led by Prospect Bay Ventures with participation from existing investors. Techlobe offers you great new ways to manage all the noise in life to effectively navigate the world in ...

[Seoul/December 31, 2019] – MD Healthcare Inc. today announced that it has scheduled a company presentation at Biotech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square. B&D Specialist Andrea McDowel...

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biotechnology company targeting cancers caused by mis-regulated gene expression, referred to as epigenetics, has announced that its chief executive officer, David Arthur, will present at the Biotech Showcase 2020 ...

NanoValent continues to progress towards its goal of moving our lead drug candidate to an IND/BLA and the clinic in 2021 and 2022. Although our “almost virtual” infrastructure has us sheltering-in-place as a regular course of business, these are by no means normal times.  Yet,...

Berwyn, PA – DEC. 24, 2019 – CuRAGE Therapeutics announced today that it is scheduled to deliver a company presentation at Biotech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square. Dr. Ihor Terlecky...

Privately-held Pacylex may have a gem in its pipeline. Pacylex is developing PCLX-001, a first-in-kind, small molecule with a novel mechanism of action believed to play a significant role in the development of certain types of blood cancers and solid tumors. Data from four dif...

In the world of pharmaceutical product development, an effective drug to treat Alzheimer's disease (AD) is the Holy Grail. Very little has been successful in this area to date. Neurodegenerative diseases remains a difficult area for new product development and Alzheimer's by f...

UGI employees continued a long-standing tradition of giving back to the community throughout the holiday season. UGI employees have shared their spirit of the season in a variety of activities that support a wide range of community organizations across Pennsylvania in providin...

As families and businesses gather to celebrate the holiday season, UGI encourages all members of the community to remember the following energy-related safety tips: Practice good safety habits when using a natural gas oven and stove.  If you use natural gas for cooking, be sur...